Terms: = Leukemia AND BRIP1, MGC126521, 83990, ENSG00000136492, FANCJ, FLJ90232, Q9BX63, MGC126523, OF AND Treatment
687 results:
1. Supportive care measures for bispecific T-cell engager therapies in haematological malignancies.
Chen LY; Kothari J
Curr Opin Support Palliat Care; 2024 Jun; 18(2):92-99. PubMed ID: 38652455
[TBL] [Abstract] [Full Text] [Related]
2. A metabolomics approach reveals metabolic disturbance of human cholangiocarcinoma cells after parthenolide treatment.
He Y; Yu Q; Ma X; Lv D; Wang H; Qiu W; Chen XF; Jiao Y; Liu Y
J Ethnopharmacol; 2024 Jun; 328():118075. PubMed ID: 38513779
[TBL] [Abstract] [Full Text] [Related]
3. Early switch from intravenous to oral antibiotic therapy in patients with cancer who have low-risk neutropenic sepsis: the EASI-SWITCH RCT.
Coyle V; Forde C; Adams R; Agus A; Barnes R; Chau I; Clarke M; Doran A; Grayson M; McAuley D; McDowell C; Phair G; Plummer R; Storey D; Thomas A; Wilson R; McMullan R
Health Technol Assess; 2024 Mar; 28(14):1-101. PubMed ID: 38512064
[TBL] [Abstract] [Full Text] [Related]
4. Novel Therapeutic Targets in Acute Myeloid leukemia (AML).
Wysota M; Konopleva M; Mitchell S
Curr Oncol Rep; 2024 Apr; 26(4):409-420. PubMed ID: 38502417
[TBL] [Abstract] [Full Text] [Related]
5. Integrating serum pharmacochemistry and network pharmacology to explore the molecular mechanisms of Acanthopanax senticosus (Rupr. & Maxim.) Harms on attenuating doxorubicin-induced myocardial injury.
Zhang X; Zhang Q; Yu M; Zhang Y; He T; Qiu Z; Qiu Y; Wang W
J Ethnopharmacol; 2024 Jan; 319(Pt 3):117349. PubMed ID: 38380572
[TBL] [Abstract] [Full Text] [Related]
6. BCR/ABL-Positive Chronic Myeloid leukemia in Children: Current treatment Approach.
Menger JM; Sathianathen RS; Sakamoto KM; Hijiya N
Curr Oncol Rep; 2024 Mar; 26(3):250-257. PubMed ID: 38340217
[TBL] [Abstract] [Full Text] [Related]
7. Frontline Therapy of CLL-Changing treatment Paradigms.
Coombs CC
Curr Hematol Malig Rep; 2024 Apr; 19(2):65-74. PubMed ID: 38337108
[TBL] [Abstract] [Full Text] [Related]
8. Bioactive triterpenoid compounds of Poria cocos (Schw.) Wolf in the treatment of diabetic ulcers via regulating the PI3K-AKT signaling pathway.
Ding X; Li S; Huang H; Shen J; Ding Y; Chen T; Ma L; Liu J; Lai Y; Chen B; Wang Y; Tan Q
J Ethnopharmacol; 2024 May; 325():117812. PubMed ID: 38301984
[TBL] [Abstract] [Full Text] [Related]
9. Prolymphocytic Leukaemia: an Update on Biology and treatment.
El-Sharkawi D; Dearden C
Curr Oncol Rep; 2024 Feb; 26(2):129-135. PubMed ID: 38214879
[TBL] [Abstract] [Full Text] [Related]
10. treatment of Richter's Transformation with Novel Therapies.
Bajwa A; Habib A; Kittai AS
Curr Hematol Malig Rep; 2024 Apr; 19(2):45-55. PubMed ID: 38194201
[TBL] [Abstract] [Full Text] [Related]
11. Chronic Lymphocytic leukemia: Time-Limited Therapy in the First-Line Setting and Role of Minimal Residual Disease.
Stumpf J; Al-Sawaf O
Curr Oncol Rep; 2024 Feb; 26(2):136-146. PubMed ID: 38175465
[TBL] [Abstract] [Full Text] [Related]
12. Blinatumomab in Practice.
Lantz J; Pham N; Jones C; Reed D; El Chaer F; Keng M
Curr Hematol Malig Rep; 2024 Feb; 19(1):1-8. PubMed ID: 38060085
[TBL] [Abstract] [Full Text] [Related]
13. Novel Biomarkers and Molecular Targets in ALL.
De Sa H; Leonard J
Curr Hematol Malig Rep; 2024 Feb; 19(1):18-34. PubMed ID: 38048037
[TBL] [Abstract] [Full Text] [Related]
14. The future of HOXA- expressing leukemias: Menin inhibitor response and resistance.
Wenge DV; Armstrong SA
Curr Opin Hematol; 2024 Mar; 31(2):64-70. PubMed ID: 38010951
[TBL] [Abstract] [Full Text] [Related]
15. Unlocking the Potential of Artificial Intelligence in Acute Myeloid leukemia and Myelodysplastic Syndromes.
Alhajahjeh A; Nazha A
Curr Hematol Malig Rep; 2024 Feb; 19(1):9-17. PubMed ID: 37999872
[TBL] [Abstract] [Full Text] [Related]
16. Oral squamous cell carcinoma arising from areas of Graft-versus-host disease: A systematic review.
Monteiro MF; Lemos JG; Pontes FS; Silva AC; Silva MH; Silva NF; Souza LL; Uchôa DC; Pontes HA
Med Oral Patol Oral Cir Bucal; 2024 Jan; 29(1):e135-e144. PubMed ID: 37992141
[TBL] [Abstract] [Full Text] [Related]
17. Pediatric acute myeloid leukemia - novel approaches.
Karol SE; Gueguen G
Curr Opin Hematol; 2024 Mar; 31(2):47-52. PubMed ID: 37982279
[TBL] [Abstract] [Full Text] [Related]
18. Towards development of biobetter: L-asparaginase a case study.
Tripathy RK; Anakha J; Pande AH
Biochim Biophys Acta Gen Subj; 2024 Jan; 1868(1):130499. PubMed ID: 37914146
[TBL] [Abstract] [Full Text] [Related]
19. Recent advances in allogeneic transplantation for acute myeloid leukemia.
Montoro J; Balaguer-Roselló A; Sanz J
Curr Opin Oncol; 2023 Nov; 35(6):564-573. PubMed ID: 37820092
[TBL] [Abstract] [Full Text] [Related]
20. Real-world expenditures and survival time after CAR-T treatment for large B-cell lymphoma in Switzerland: a retrospective study using insurance claims data.
Trottmann M; Blozik E; Hilbig M; LoVerdi D; Pedruzzi M; Scherer T; Weiss M; Pletscher M; Meier N
Swiss Med Wkly; 2023 Sep; 153():3441. PubMed ID: 37774383
[TBL] [Abstract] [Full Text] [Related]
[Next]
